Related Experiment Video
Updated: Jun 3, 2026

Fixed Target Serial Data Collection at Diamond Light Source
Published on: February 26, 2021
Conference report: inaugural Target Discovery World Congress 2009
1High Throughput Screening Laboratories, Molecular Biosciences, University of Kansas, Structural Biology Center, 2121 Simons Drive, Room 1059, Lawrence, KS 66047, USA. rathnam@ku.edu
Abstract:
Target Discovery World Congress 2009 is the first of its kind in a series of trend-setting conferences conceived and organized by Select Biosciences. This was a multi-track event with a combined exhibition covering current potential drug targets, the platforms used to screen for hits and hit-to-lead methods. This conference included all the major drug-target classes: ion channels, protein kinases, G-protein-coupled receptors, nuclear receptors and ubiquitin pathways, as well as a special session devoted to screening platforms in academia. Each of the sessions started with a noteworthy keynote presentation by a world-class expert. There were a total of 44 high-quality podium presentations and 16 poster presentations.
Insights
The Target Discovery World Congress 2009 convened experts to discuss drug target identification and screening platforms. It covered major drug-target classes and hit-to-lead methodologies for drug discovery.
Area of Science:
- Drug Discovery and Development
- Pharmacology
- Biotechnology
Background:
- The Target Discovery World Congress 2009, organized by Select Biosciences, was a premier event focusing on novel drug targets.
- The conference addressed critical aspects of the drug discovery pipeline, from target identification to hit-to-lead optimization.
Framework:
- The event featured a multi-track program with an integrated exhibition.
- Keynote presentations by world-class experts initiated each session.
- Sessions covered major drug-target classes including ion channels, protein kinases, G-protein-coupled receptors, nuclear receptors, and ubiquitin pathways.
Implementation:
- The congress included 44 podium presentations and 16 poster presentations.
- A dedicated session focused on screening platforms utilized in academic research.
- Discussions encompassed platforms for screening hits and advancing them to lead compounds.
Implications:
- The congress facilitated knowledge exchange on cutting-edge drug target discovery and screening technologies.
- It highlighted advancements in understanding various drug-target classes and their therapeutic potential.
- The event underscored the importance of integrated approaches in modern drug development.
Related Concept Videos
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Drug Discovery: Overview
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Types of Reports II: Incident or Occurrence Report
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Types of Reports I: Hand-off Report
Following are the key components and categories of hand-off reports:
Purpose and Process:
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
